Chugai Pharmaceutical Co., Ltd. (the “Company”) announced that, based on the recommendation of the Appointment Committee, the Company resolved at the Board of Directors Meeting held today to appoint Osamu Okuda, currently Representative Director, President and Chief Operating Officer (COO), as Chief Executive Officer (CEO) as of March 23, 2021.

1.　Reason for change

Chugai aims to become a top innovator in the healthcare industry that contributes to the realization of advanced and sustainable patient-centric healthcare and has been contributing to the resolution of social issues and growing together with society through our business activities. The appointment of a new CEO has been decided to promote our new growth strategy, TOP I 2030, formulated for the year 2030, to achieve sustainable growth and development of the Chugai group and further enhancing corporate value under a new management structure.

Under the new management structure, Tatsuro Kosaka will continue to chair the board in his capacity as Representative Director and Chairman. Dr. Osamu Okuda will bear the role and responsibilities for decision-making over company-wide strategies and the execution of operations in his capacity as Representative Director, President and CEO.

2.　Details of change

3.　Career summary of the representative director candidates

4. Effective date
March 23, 2021